GEN: Your company maintains that the supply chain of single-use assemblies is the biggest bottleneck in biopharmaceutical manufacturing. Can you talk about why that is the case and how you address ...

Today’s most common biopharmaceutical manufacturing systems require the handling, transferring, processing, and purification of large-molecule drugs produced in living cells—cultured animal cells, ...

The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

The MarketWatch News Department was not involved in the creation of this content. Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and ...

Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...

TOKYO--(BUSINESS WIRE)--Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process ...

Raman spectroscopy has proven its ability to accurately detect subtle changes in complex aqueous systems, greatly broadening its application scope, including monitoring biopharmaceutical processes ...

Process development teams have started using real-time monitoring of intricate parameters during manufacturing processes to better comprehend and manage mammalian cell cultivations in the ...

The regulatory framework around biopharmaceutical manufacturing is exacting and continuously evolving. Companies must meet diverse global requirements while staying agile enough to deliver on ...

Biopharmaceuticals, also known as biologics, are a class of medicines produced using living systems such as microorganisms, plant or animal cells, or recombinant DNA technology. Unlike traditional ...